Page last updated: 2024-10-31

mianserin and Dysphagia

mianserin has been researched along with Dysphagia in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research Excerpts

ExcerptRelevanceReference
"The treatment of major depressive disorder requires prolonged pharmacotherapy with antidepressants in order to resolve the current episode and reduce the risk for recurrence of depressive symptoms."2.46Improving medication compliance in patients with depression: Use of orodispersible tablets. ( Navarro, V, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Navarro, V1

Reviews

1 review available for mianserin and Dysphagia

ArticleYear
Improving medication compliance in patients with depression: Use of orodispersible tablets.
    Advances in therapy, 2010, Volume: 27, Issue:11

    Topics: Administration, Oral; Antidepressive Agents; Citalopram; Deglutition Disorders; Depressive Disorder,

2010